{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Deformity%3B+Skin&page=56", "query": { "condition": "Deformity; Skin", "page": 56 }, "page_size": 10 }, "pagination": { "page": 56, "page_size": 10, "total_count": 1851, "total_pages": 186, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Deformity%3B+Skin&page=57&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Deformity%3B+Skin&page=55&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-02T00:24:55.594Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01556568", "title": "Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomyopathy", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cardiomegaly" ], "interventions": [ { "name": "MEK162", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Array Biopharma, now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2012-02", "completion_date": null, "has_results": false, "last_update_posted_date": "2020-10-06", "last_synced_at": "2026-11-02T00:24:55.594Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01556568" }, { "nct_id": "NCT03050268", "title": "Familial Investigations of Childhood Cancer Predisposition", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Acute Leukemia", "Adenomatous Polyposis", "Adrenocortical Carcinoma", "AML", "BAP1 Tumor Predisposition Syndrome", "Carney Complex", "Choroid Plexus Carcinoma", "Constitutional Mismatch Repair Deficiency Syndrome", "Diamond-Blackfan Anemia", "DICER1 Syndrome", "Dyskeratosis Congenita", "Emberger Syndrome", "Familial Acute Myeloid Leukemia", "Familial Adenomatous Polyposis", "Fanconi Anemia", "Familial Cancer", "Familial Wilms Tumor", "Familial Neuroblastoma", "GIST", "Hereditary Breast and Ovarian Cancer", "Hereditary Paraganglioma-Pheochromocytoma Syndrome", "Hodgkin Lymphoma", "Juvenile Polyposis", "Li-Fraumeni Syndrome", "Lynch Syndrome", "MDS", "Melanoma Syndrome", "Multiple Endocrine Neoplasia Type 1", "Multiple Endocrine Neoplasia Type 2", "Neuroblastoma", "Neurofibromatosis Type 1", "Neurofibromatosis Type II", "Nevoid Basal Cell Carcinoma Syndrome", "Non Hodgkin Lymphoma", "Noonan Syndrome and Other Rasopathy", "Overgrowth Syndromes", "Pancreatic Cancer", "Peutz-Jeghers Syndrome", "Pheochromocytoma/Paraganglioma", "PTEN Hamartoma Tumor Syndrome", "Retinoblastoma", "Rhabdoid Tumor Predisposition Syndrome", "Rhabdomyosarcoma", "Rothmund-Thomson Syndrome", "Tuberous Sclerosis", "Von Hippel-Lindau Disease" ], "interventions": [], "intervention_types": [], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1500, "start_date": "2017-04-06", "completion_date": "2037-03-31", "has_results": false, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-11-02T00:24:55.594Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT03050268" }, { "nct_id": "NCT06461897", "title": "A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Upadacitinib", "type": "DRUG" }, { "name": "Dupilumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "2 Years to 11 Years" }, "enrollment_count": 699, "start_date": "2024-08-19", "completion_date": "2029-11", "has_results": false, "last_update_posted_date": "2026-10-16", "last_synced_at": "2026-11-02T00:24:55.594Z", "location_count": 31, "location_summary": "Little Rock, Arkansas • Palo Alto, California • Sacramento, California + 27 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06461897" }, { "nct_id": "NCT05145010", "title": "Extension Study of Infigratinib in Children With Achondroplasia (ACH)", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Achondroplasia" ], "interventions": [ { "name": "Infigratinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "QED Therapeutics, a BridgeBio company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "3 Years to 18 Years" }, "enrollment_count": 325, "start_date": "2021-12-06", "completion_date": "2032-02-01", "has_results": false, "last_update_posted_date": "2026-10-26", "last_synced_at": "2026-11-02T00:24:55.594Z", "location_count": 8, "location_summary": "Oakland, California • Aurora, Colorado • Wilmington, Delaware + 5 more", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Wilmington", "state": "Delaware" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Columbia", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05145010" }, { "nct_id": "NCT03566615", "title": "Does the Cap Increase the Finding of Polyps When Water Exchange Colonoscopy is Used", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Colonoscopy", "Polyp of Colon" ], "interventions": [ { "name": "CAP-straight", "type": "DEVICE" }, { "name": "CAP-daisy", "type": "DEVICE" }, { "name": "water", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "VA Greater Los Angeles Healthcare System", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "50 Years to 75 Years" }, "enrollment_count": 1630, "start_date": "2018-07-01", "completion_date": "2023-01-31", "has_results": false, "last_update_posted_date": "2022-10-06", "last_synced_at": "2026-11-02T00:24:55.594Z", "location_count": 2, "location_summary": "Mather, California • Palo Alto, California", "locations": [ { "city": "Mather", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03566615" }, { "nct_id": "NCT03064074", "title": "Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Osteogenesis Imperfecta" ], "interventions": [ { "name": "Fresolimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2017-11-15", "completion_date": "2022-07-04", "has_results": true, "last_update_posted_date": "2024-12-04", "last_synced_at": "2026-11-02T00:24:55.594Z", "location_count": 2, "location_summary": "Portland, Oregon • Houston, Texas", "locations": [ { "city": "Portland", "state": "Oregon" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03064074" }, { "nct_id": "NCT03548779", "title": "North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Epilepsy; Seizure", "Neuromuscular Diseases", "Brain Malformation", "Intellectual Disability", "Autism Spectrum Disorder", "Hypotonia", "Inborn Errors of Metabolism", "Movement Disorders", "Genetic Disease", "Development Delay", "Chromosome Abnormality", "Hearing Loss", "Dysmorphic Features", "Skeletal Dysplasia", "Congenital Abnormality", "Microcephaly", "Macrocephaly" ], "interventions": [ { "name": "Pre-visit prep", "type": "BEHAVIORAL" }, { "name": "usual care + exome seq", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "BEHAVIORAL", "DIAGNOSTIC_TEST" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": null, "sex": "ALL", "summary": "0 Years and older" }, "enrollment_count": 548, "start_date": "2018-09-28", "completion_date": "2024-09-08", "has_results": true, "last_update_posted_date": "2025-05-13", "last_synced_at": "2026-11-02T00:24:55.594Z", "location_count": 3, "location_summary": "Asheville, North Carolina • Chapel Hill, North Carolina • Greenville, North Carolina", "locations": [ { "city": "Asheville", "state": "North Carolina" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Greenville", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03548779" }, { "nct_id": "NCT05312697", "title": "Long-term Extension Study of Setrusumab in Adults With Type I, III, or IV Osteogenesis Imperfecta", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Osteogenesis Imperfecta" ], "interventions": [ { "name": "Setrusumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Ultragenyx Pharmaceutical Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "19 Years to 80 Years" }, "enrollment_count": 2, "start_date": "2022-04-28", "completion_date": "2022-07-07", "has_results": true, "last_update_posted_date": "2025-07-23", "last_synced_at": "2026-11-02T00:24:55.594Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT05312697" }, { "nct_id": "NCT03784859", "title": "Tissue Expansion in Breast Reconstruction Without Drains", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer", "Hereditary Breast and Ovarian Cancer Syndrome", "Breast Implant; Complications" ], "interventions": [ { "name": "Insertion of Tissue Expander with Fluid Reservoir", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "FEMALE", "summary": "21 Years and older · Female only" }, "enrollment_count": 5, "start_date": "2019-02-25", "completion_date": "2020-10-02", "has_results": false, "last_update_posted_date": "2020-10-06", "last_synced_at": "2026-11-02T00:24:55.594Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03784859" }, { "nct_id": "NCT02832674", "title": "Safety and Effectiveness Evaluation of the Device in Achieving Submental Lift", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Skin Laxity" ], "interventions": [ { "name": "Percutaneous Radiofrequency single treatment", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "ThermiGen, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "35 Years to 65 Years" }, "enrollment_count": 72, "start_date": "2016-06-25", "completion_date": "2017-04-08", "has_results": true, "last_update_posted_date": "2018-05-01", "last_synced_at": "2026-11-02T00:24:55.594Z", "location_count": 1, "location_summary": "Montclair, New Jersey", "locations": [ { "city": "Montclair", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02832674" } ] }